Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Arthritis, Rheumatoid × CT-P13 × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Urogenital Neoplasms 2 Inflammatory Bowel Diseases 2 Crohn Disease 2 Colitis, Ulcerative 2 Colitis 2 Carcinoma, Non-Small-Cell Lung 2 Takayasu Arteritis 1 Melanoma 1 Lung Neoplasms 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1

Interventions

Etanercept 16 Adalimumab 16 Methotrexate 10 Infliximab 8 tocilizumab 7 golimumab 6 Rituximab 6 tofacitinib 5 Abatacept 5 Tumor Necrosis Factor Inhibitors 4 Certolizumab Pegol 4 olokizumab 3 Saline Solution 2 RC-18 2 Nivolumab 2 Leflunomide 2 Antirheumatic Agents 2 veltuzumab 1 upadacitinib 1 secukinumab 1 sarilumab 1 mavrilimumab 1 entecavir 1 baricitinib 1 andecaliximab 1 Vitamin D 1 Vaccines 1 Syringes 1 Surveys and Questionnaires 1 Sulfasalazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03348046 2020-03-04

PASSRRA

Hikma Pharmaceuticals LLC

Arthritis, Rheumatoid, Autoimmune Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡